Rights issue 2025
Subscribe through Eminova Fondkommission
Subscribe through Avanza
Subscribe through Nordnet
SUMMARY OF THE RIGHTS ISSUE
• The Board of Directors in Qlife Holding AB (publ) ("Qlife" or the "Company") has resolved to carry out an issue of 5,883,817 shares with preferential rights for the Company's existing shareholders (the "Rights Issue"). Provided that the Rights Issue is fully subscribed, the Company will receive initial proceeds of approximately SEK 11.8 million before deduction of issue costs.
• The proceeds from the Rights Issue will primarily finance commercialization, clinical trials, and general administration.
• Shareholders who were registered in the share register maintained by Euroclear Sweden AB on the record date of 7 February 2025 received five (5) subscription rights for each share held. Six (6) subscription rights entitle the holder to subscribe for one (1) share.
• The subscription price in the Rights Issue is SEK 2 per share.
• The subscription period in the Rights Issue runs between 11 February - 25 February 2025.
• The Rights Issue is covered by guarantee commitments of approximately 75.9 percent.
Timeline for the Rights Issue
- 11 February - 25 February 2025:
- 11 February - 19 February 2025: Trading in subscription rights
- 11 February 2025 until the Rights Issue is registered with the Swedish Companies Registration Office: Trading in BTA
- 27 February 2025: Expected announcement of the outcome in the Rights Issue
Documents